Author Details

Демидов, Н. А

Issue Section Title File
No 17 (2015) Articles Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
No 5 (2017) Articles EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
No 4 (2018) Articles MOSCOW EXPERIENCE OF APPLICATION OF A NEW LONG-ACTING INSULIN ANALOGUE
No 11 (2018) Articles Initiation of insulin therapy in patients with type 2 diabetes mellitus according to the Federal Diabetes Register in Moscow
No 11 (2018) Articles Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Vol 26, No 4 (2019) Articles Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Vol 26, No 14 (2019) Articles Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference?
Vol 26, No 14 (2019) Articles Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals
Vol 26, No 14 (2019) Articles What can affect the effectiveness of basal insulin therapy for patients with type 2 diabetes mellitus: analysis of the results of real clinical practice according to the diabetes register
Vol 27, No 12 (2020) Articles Modern approaches to using the FreeStyle Libre Flash glucose monitoring system
Vol 28, No 4 (2021) Articles Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Vol 28, No 4 (2021) Articles New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Vol 29, No 4 (2022) Articles The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice
Vol 29, No 11/12 (2022) Articles Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies